Bosh sahifaPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
1,17 $
Dastlabki sotuv:(0,00%)0,00
1,17 $
Yopilgan:16-mar, 4:54:58 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
1,25 $
Kunlik diapazon
1,17 $ - 1,29 $
Yillik diapazon
0,81 $ - 4,19 $
Bozor kapitalizatsiyasi
13,59 mln USD
Oʻrtacha hajm
7,43 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 1,06 mln | 53,41% |
Sof foyda | -2,37 mln | -45,82% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,15 | — |
EBITDA | -2,53 mln | -51,31% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 21,03 mln | 290,77% |
Jami aktivlari | 21,49 mln | 274,47% |
Jami passivlari | 1,34 mln | 32,02% |
Umumiy kapital | 20,15 mln | — |
Tarqatilgan aksiyalar | 11,62 mln | — |
Narxi/balansdagi bahosi | 0,72 | — |
Aktivlardan daromad | -38,40% | — |
Kapitaldan daromad | -42,25% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -2,37 mln | -45,82% |
Operatsiyalardan naqd pul | -2,08 mln | -51,64% |
Sarmoyadan naqd pul | 0,00 | -100,00% |
Moliyadan naqd pul | 12,40 mln | 815,50% |
Naqd pulning sof oʻzgarishi | 10,33 mln | 129 175,00% |
Boʻsh pul | -1,29 mln | -64,92% |
Haqida
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Tashkil etilgan
2011
Sayt
Xodimlar soni
6
